Comparative Pharmacology
Head-to-head clinical analysis: ECONOCHLOR versus FML S.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ECONOCHLOR versus FML S.
ECONOCHLOR vs FML-S
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Econazole nitrate inhibits fungal cytochrome P450 14α-demethylase, blocking ergosterol synthesis, disrupting fungal cell membrane integrity and function.
Fluorometholone is a synthetic corticosteroid that binds to the glucocorticoid receptor, modulating gene expression to inhibit phospholipase A2 activity, reduce prostaglandin and leukotriene synthesis, and suppress cytokine production. This results in decreased inflammation, edema, and immune cell infiltration. Sulfacetamide is a sulfonamide antibiotic that competitively inhibits dihydropteroate synthase, blocking folate synthesis and bacterial growth.
0.12 mg/kg IV bolus over 30 seconds, followed by continuous IV infusion at 0.12-0.6 mg/kg/h.
1-2 drops of 0.1% ophthalmic suspension into the conjunctival sac every 4 hours; may increase to every 2 hours in severe inflammation.
None Documented
None Documented
Terminal half-life: 8-10 hours in adults with normal renal function; prolonged to 15-20 hours in renal impairment (CrCl <30 mL/min).
2.8-3.5 hours; prolonged to 8-12 hours in renal impairment or in neonates
Renal: 80-90% as unchanged drug; fecal: <1%; biliary: minimal.
Renal (65-75% as unchanged drug and metabolites), biliary/fecal (15-25%)
Category C
Category C
Ophthalmic Antibiotic
Ophthalmic Antibiotic/Corticosteroid Combination